全文获取类型
收费全文 | 292篇 |
免费 | 44篇 |
国内免费 | 5篇 |
专业分类
儿科学 | 158篇 |
妇产科学 | 3篇 |
基础医学 | 44篇 |
临床医学 | 8篇 |
内科学 | 32篇 |
神经病学 | 1篇 |
特种医学 | 3篇 |
外科学 | 29篇 |
综合类 | 17篇 |
预防医学 | 2篇 |
药学 | 5篇 |
肿瘤学 | 39篇 |
出版年
2024年 | 2篇 |
2023年 | 9篇 |
2022年 | 7篇 |
2021年 | 11篇 |
2020年 | 17篇 |
2019年 | 15篇 |
2018年 | 19篇 |
2017年 | 13篇 |
2016年 | 11篇 |
2015年 | 9篇 |
2014年 | 20篇 |
2013年 | 19篇 |
2012年 | 19篇 |
2011年 | 11篇 |
2010年 | 9篇 |
2009年 | 13篇 |
2008年 | 7篇 |
2007年 | 13篇 |
2006年 | 11篇 |
2005年 | 16篇 |
2004年 | 15篇 |
2003年 | 8篇 |
2002年 | 5篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 4篇 |
1998年 | 7篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 6篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1987年 | 1篇 |
1985年 | 5篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有341条查询结果,搜索用时 15 毫秒
31.
目的:检测化疗前后肝母细胞瘤(HB)细胞凋亡,评价其在判断HB预后及其化疗疗效中的价值并探讨化疗机制。方法:应用TUNEL技术检测13例HB化疗前后标本细胞凋亡。结果:化疗前后标本的可见HB细胞凋亡;化疗后凋亡指数(PCAI)较化疗前自发性凋亡指数(SAI)显著增高(P〈0.05),PCAI与SAI呈正相关(r=0.907),化疗后肿瘤体积(直径)减少值与SAI呈正相关(r=0.694),SAI高 相似文献
32.
33.
Keizo Sugino MD Kiyohiko Dohi Toshiya Matsuyama Toshimasa Asahara Masami Yamamoto 《Surgery today》1989,19(4):489-493
We present herein a rare case of hepatoblastoma occurring in an adult male. The patient was 22 years old and his laboratory
investigations on admission showed a marked elevation of α-fetoprotein in the serum. CT scan and other examinations revealed
a primary tumor, 6.5 cm in size, in the left hepatic lobe with metastasis in the head of the pancreas. Thus, left hepatic
lobectomy and pancreaticoduodenectomy were performed, but metastasis to the right hepatic lobe, left lung and abdominal skin
were found 2 months later. Despite repeated courses of chemotherapy with adriamycin and cisplatin, the patient died 9 months
after his operation. Pathological findings revealed poorly differentiated type hepatoblastoma. A review of the literature
revealed only twelve other such cases. 相似文献
34.
目的筛选肝母细胞瘤(hepatoblastoma)组织与小儿正常肝脏组织中的差异表达基因,探究肝母细胞瘤的发病机制,为其诊断和治疗提供新方向。方法从GEO数据库中检索获取肝母细胞瘤组织和小儿正常肝脏组织的芯片数据,通过R语言软件RSTUDIO筛选芯片中的差异表达基因,使用DAVID数据库对筛选所得的差异表达基因进行功能注释,通过STRING数据库构建蛋白质相互作用网络,并进行中心性分析。结果经筛选共获得肝母细胞瘤组织中290个差异表达基因,其中上调基因99个,下调基因191个(P0.05)。GO(Gene Ontology)功能注释分析显示,上调差异基因主要涉及细胞分裂、细胞外外泌体、金属离子结合等94个功能簇,下调差异基因主要涉及脂蛋白代谢、细胞外外泌体、血红素结合等100个功能簇。蛋白质相互作用网络分析示IMPDH2、AGXT、ALDH1A1、ALDH2、PFAS、SERPINC1、AGXT2、KNG1、APOA1、MAT1A、APOC3和HSD17B6 12个基因为与其他节点关系最密切的核心调控基因。结论通过多种生物信息学方法联合分析三组高通量基因芯片,获得了肝母细胞瘤组织与正常小儿肝脏组织间的差异表达基因,并进一步从不同角度分析肝母细胞瘤异常增殖、转移等恶性生物学过程的发生机制,为肝母细胞瘤的诊断和治疗提供新方向。 相似文献
35.
Settimo Caruso Giuseppe Mamone Gianluca Marrone Mariapina Milazzo Vincenzo Carollo Roberto Miraglia Luigi Maruzzelli Armando Pasta Marta I. Minervini Marco Spada Silvia Riva Angelo Luca Bruno Gridelli 《Clinical transplantation》2010,24(5):592-598
Caruso S, Mamone G, Marrone G, Milazzo M, Carollo V, Miraglia R, Maruzzelli L, Pasta A, Minervini MI, Spada M, Riva S, Luca A, Gridelli B. Focal liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay.Clin Transplant 2009: DOI: 10.1111/j.1399‐0012.2009.01139.x© 2009 John Wiley & Sons A/S. Abstract: The aim of this review is to present the wide spectrum of common and uncommon focal liver diseases affecting neonatal and pediatric liver transplant candidates, analyzed using ultrasonography (US), 16‐ or 64‐multidetector row helical CT (MDCT) and 1.5‐T magnetic resonance (MR) fast imaging. Correlation of imaging findings and explanted liver or histology is illustrated in representative cases. Associated uncommon congenital anomalies are shown. 相似文献
36.
Bcl-2 gene silencing in pediatric epithelial liver tumors 总被引:3,自引:0,他引:3
Warmann SW Frank H Heitmann H Ruck P Herberts T Seitz G Fuchs J 《The Journal of surgical research》2008,144(1):43-48
BACKGROUND: Proteins of the Bcl-2 family prevent cells of various tumor types from undergoing apoptosis and thus contribute to their chemotherapy resistance. The phenotype of multidrug resistance is a major factor for poor treatment results of advanced epithelial liver tumors in children. The role of Bcl-2 proteins in these tumors is yet unclear. The purpose of this study was to analyze the influence of Bcl-2 on the chemotherapy resistance of hepatoblastoma (HB) and pediatric hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Bcl-2 expression was analyzed in the HB cell lines HUH6 and HepT1 as well as in the HCC cell line HepG2 before and after treatment with cisplatin, doxorubicin, taxol, and etoposid. Silencing of the Bcl-2 gene was performed via RNA interference using specific siRNA. Treatment efficiencies of cytotoxic agents were assessed against original and Bcl-2 siRNA transfected tumor cells. RESULTS: The mixed HB cell line HUH6 showed a relevant amount of Bcl-2 expression, which increased after chemotherapy. In these cells Bcl-2 appeared within the nuclei and the cytosol. Treatment with all cytotoxic agents was significantly improved through Bcl-2 siRNA (P < 0.001-0.0054) in this cell line. There was no effect of Bcl-2 siRNA in HepT1 and HepG2 cells. CONCLUSIONS: Bcl-2 seems to play a role in antiapoptotic mechanisms of some HB subtypes. Thus, this gene might serve as target for a gene-directed adjuvant therapy. Further studies seem necessary to clear the susceptibility of pediatric epithelial liver tumors toward the described approach. 相似文献
37.
38.
Georgios P. Fragulidis Konstantinos Chondrogiannis Antonios Vezakis Aikaterini Melemeni Agatha Kondi‐Pafiti Elias Primetis Andreas Polydorou Dionysios C. Voros 《Hepatology research》2013,43(3):320-326
Hepatoblastoma, a malignant tumor which arises occasionally in older children but very rarely in adults, exhibits divergent differentiation with embryonal cells, fetal hepatocytes and immature elements. This report describes an embryonal type hepatoblastoma with neuroendocrine differentiation in a 16‐year‐old patient, which was diagnosed postoperatively. Clinical and radiologic work‐up failed to reveal a primary gastrointestinal malignancy and no primary lesions were detected in any other organ. This feature of hepatoblastoma is considered to be a multidirectional differentiation of the small epithelial or stem cells of the liver. At 2‐year follow up, the patient remains symptom‐free, with normal laboratory and diagnostic imaging studies, and no recurrent or metastatic disease identified. 相似文献
39.
Using an indirect immunofluorescence assay, we looked for the presence of immunoreactive prothrombin-like material in human tumor cell and fibroblast cultures. Prothrombin-like material was found in one hepatoblastoma, one choroidal melanoma, and 3/7 neuroectodermal cell lines. However, it was not found in peripheral melanoma or fibroblast cells. 相似文献
40.
We report the use of sorafenib and bevacizumab in combination for a patient with recurrent metastatic hepatoblastoma (HB). This combination demonstrated activity against our patient's refractory HB that had been extensively treated with multiple prior chemotherapeutic regimens. The patient had stabilization of radiographic disease coupled with an 83% decrease in his alpha‐fetoprotein level. Given the response in this setting and the paucity of other available options, consideration could be given to using this combination as therapy in patients with recurrent HB who have failed more traditional agents. Pediatr Blood Cancer 2012; 59: 939–940. © 2012 Wiley Periodicals, Inc. 相似文献